van Heesbeen R, Bastian AR, Omoruyi E, Rosen J, et al. Immunogenicity and safety of different dose levels of Ad26.RSV.preF/RSV preF protein vaccine in adults aged 60 years and older: A randomized, double-blind, placebo-controlled, phase 2a study. Vaccine 2024;42:126273.
PMID: 39276619